Background illustration for clinical trials search

Paid Clinical Trials Texas

Discover 5,035 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Featured

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

for
Neovascular Age-related Macular Degeneration
Location: Hickory NC, Austin TX
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT04853251

Recruiting
Featured

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

for
Chronic Migraine
Location: Nashua NH, Philadelphia PA, Miami FL, Weston FL,
Sponsor: AbbVie

Sex: All

Age: 12 - 17

Code: NCT06810505

Phase 3, Recruiting
Featured

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Nashua NH, Stamford CT, Morristown NJ, Philadelphia PA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Burlington MA, East Greenwich RI, Carmel NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting
Featured

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

for
Episodic Migraine
Location: Morristown NJ, Philadelphia PA, Franklin VA, Miami FL,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05711394

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Burlington MA, East Greenwich RI, Framingham MA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

for
Depression, Bipolar I Disorder
Location: Irvington NJ, Miami FL, Tamarac FL, Doral FL,
Sponsor: AbbVie

Sex: All

Age: 10 - 17

Code: NCT04777357

Phase 3, Recruiting
Active & Responsive

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

for
Lactating Women on Select DOI,
Location: Durham NC, Pittsburgh PA, Chicago IL, Minneapolis MN,
Sponsor: Duke University

Sex: All

Age: 0+

Code: NCT03511118

Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Richmond VA, Durham NC,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase 1, Recruiting
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: London, Boston MA, Providence RI, Trois-Rivieres,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase 2, Recruiting
Active & Responsive

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

for
Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 10+

Code: NCT04199026

Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Rimouski, Boston MA, Quebec, Stony Brook NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase 3, Recruiting
Active & Responsive

A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

for
Graves' Disease
Location: Hamilton NJ, Lutherville MD, Richmond VA, Doral FL,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT07722546

Phase 2, Recruiting
Active & Responsive

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

for
Obesity, Women (Between 30 to 60 Years Old)
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: Female

Age: 30 - 60

Code: NCT07480109

Recruiting
Active & Responsive

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, Greenville NC, Chicago IL, Minneota MN,
Sponsor: Ascendis Pharma Bone Diseases A/S

Sex: All

Age: 18+

Code: NCT07081997

Phase 3, Recruiting
Active & Responsive

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Prilenia

Sex: All

Age: 18 - 70+

Code: NCT07322003

Phase 3, Recruiting
Active & Responsive

Study of DISC-0974-201 in Participants With IBD and Anemia

for
Inflammatory Bowel Disease (IBD), Anemia,
Location: Providence RI, Miami Lakes FL, Miami FL, Doral FL,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT07368972

Phase 2, Recruiting
Active & Responsive

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Carmel IN, La Crosse WI, Dallas TX, Reno NV
Sponsor: Complement Therapeutics

Sex: All

Age: 55+

Code: NCT07392255

Phase 1, Phase 2, Recruiting
Active & Responsive

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222800

Phase 3, Recruiting
Active & Responsive

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Location: New Bedford MA, Providence RI, Hamden CT, Quebec,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07165028

Phase 3, Recruiting

Popular cities in Texas

With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.

Why choose Texas for clinical trials?

Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.

By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.

Common conditions studied in Texas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Texas